BPC
CYTK icon

Banque Pictet & Cie’s Cytokinetics CYTK Stock Holding History

Banque Pictet & Cie’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,184
Closed -$393K – 419
2025
Q4 		$393K Sell
6,184
-1,455
-19% -$90.5K ﹤0.01% 328
2025
Q3 		$420K Sell
7,639
-49
-0.6% -$2.02K ﹤0.01% 337
2025
Q2 		$254K Sell
7,688
-515
-6% -$17.9K ﹤0.01% 344
2025
Q1 		$330K Buy
+8,203
New +$377K ﹤0.01% 351

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Banque Pictet & Cie's CYTK Position: Q1 2026 in Review

Banque Pictet & Cie sold out of Cytokinetics (CYTK) in Q1 2026, closing a stake of 6,184 shares — an estimated $393K sold.

Banque Pictet & Cie first reported a position in CYTK in Q1 2025 and held it in 4 quarters. The position peaked at $420K in Q3 2025. 440 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • Banque Pictet & Cie reported no remaining Cytokinetics position as of Q1 2026 after selling out during the quarter.
  • Banque Pictet & Cie sold 6,184 Cytokinetics shares in Q1 2026, an estimated $393K.
  • Banque Pictet & Cie first reported a position in Cytokinetics in Q1 2025 and held it in 4 quarters.
  • Banque Pictet & Cie's Cytokinetics position peaked at $420K in Q3 2025.
  • 440 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Banque Pictet & Cie's 13F filing for Q1 2026, filed 14 Apr 2026.